SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-005932
Filing Date
2022-01-20
Accepted
2022-01-20 16:10:47
Documents
45
Period of Report
2022-01-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tm223056d1_8k.htm   iXBRL 8-K 30209
2 EXHIBIT 99.1 tm223056d1_ex99-1.htm EX-99.1 49911
6 GRAPHIC tm223056d1_ex99x1x001.jpg GRAPHIC 87675
7 GRAPHIC tm223056d1_ex99x1x002.jpg GRAPHIC 128637
8 GRAPHIC tm223056d1_ex99x1x003.jpg GRAPHIC 106659
9 GRAPHIC tm223056d1_ex99x1x004.jpg GRAPHIC 114703
10 GRAPHIC tm223056d1_ex99x1x005.jpg GRAPHIC 69227
11 GRAPHIC tm223056d1_ex99x1x006.jpg GRAPHIC 59513
12 GRAPHIC tm223056d1_ex99x1x007.jpg GRAPHIC 67201
13 GRAPHIC tm223056d1_ex99x1x008.jpg GRAPHIC 67122
14 GRAPHIC tm223056d1_ex99x1x009.jpg GRAPHIC 81860
15 GRAPHIC tm223056d1_ex99x1x010.jpg GRAPHIC 68278
16 GRAPHIC tm223056d1_ex99x1x011.jpg GRAPHIC 82434
17 GRAPHIC tm223056d1_ex99x1x012.jpg GRAPHIC 63068
18 GRAPHIC tm223056d1_ex99x1x013.jpg GRAPHIC 65632
19 GRAPHIC tm223056d1_ex99x1x014.jpg GRAPHIC 66693
20 GRAPHIC tm223056d1_ex99x1x015.jpg GRAPHIC 69275
21 GRAPHIC tm223056d1_ex99x1x016.jpg GRAPHIC 83917
22 GRAPHIC tm223056d1_ex99x1x017.jpg GRAPHIC 76498
23 GRAPHIC tm223056d1_ex99x1x018.jpg GRAPHIC 88648
24 GRAPHIC tm223056d1_ex99x1x019.jpg GRAPHIC 67074
25 GRAPHIC tm223056d1_ex99x1x020.jpg GRAPHIC 61637
26 GRAPHIC tm223056d1_ex99x1x021.jpg GRAPHIC 145422
27 GRAPHIC tm223056d1_ex99x1x022.jpg GRAPHIC 119275
28 GRAPHIC tm223056d1_ex99x1x023.jpg GRAPHIC 84154
29 GRAPHIC tm223056d1_ex99x1x024.jpg GRAPHIC 67868
30 GRAPHIC tm223056d1_ex99x1x025.jpg GRAPHIC 97918
31 GRAPHIC tm223056d1_ex99x1x026.jpg GRAPHIC 69803
32 GRAPHIC tm223056d1_ex99x1x027.jpg GRAPHIC 84999
33 GRAPHIC tm223056d1_ex99x1x028.jpg GRAPHIC 60602
34 GRAPHIC tm223056d1_ex99x1x029.jpg GRAPHIC 59690
35 GRAPHIC tm223056d1_ex99x1x030.jpg GRAPHIC 91180
36 GRAPHIC tm223056d1_ex99x1x031.jpg GRAPHIC 80988
37 GRAPHIC tm223056d1_ex99x1x032.jpg GRAPHIC 91814
  Complete submission text file 0001104659-22-005932.txt   3894488

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ikt-20220120.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ikt-20220120_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ikt-20220120_pre.xml EX-101.PRE 22598
39 EXTRACTED XBRL INSTANCE DOCUMENT tm223056d1_8k_htm.xml XML 3716
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39676 | Film No.: 22542418
SIC: 2836 Biological Products, (No Diagnostic Substances)